HLB Therapeutics.
₩8,690
2
-₩210-2.36% Friday 06:30
Statistik
Harga Tertinggi Hari
8,900
Harga Terendah Hari
8,500
52M Tertinggi
17,700
52M Terendah
2,840.58
Volum
328,420
Volum Purata
1,072,974
Kapasiti Pasaran
685.27B
Nisbah P/E
-
Pendapatan Dividen
-
Dividen
-
Pendapatan
13MayDijangka
EPS yang dijangka
N/A
EPS sebenar
N/A
Orang Lain Juga Mengikuti
Senarai ini berdasarkan senarai pantau orang di Stock Events yang mengikuti 115450.KQ. Ini bukan cadangan pelaburan.
Peserta
Senarai ini adalah analisis berdasarkan peristiwa pasaran terkini. Ini bukan cadangan pelaburan.
Seegene
096530.KQ
Kapasiti Pasaran1.17T
Celltrion Health Care
091990.KQ
Kapasiti Pasaran11.33T
Access Bio
950130.KQ
Kapasiti Pasaran224.17B
Mengenai
HLB Therapeutics Co.,Ltd., a biotech company, develops pharmaceutical products in South Korea and internationally. It is developing GBT-201 using Thymosin beta for the treatment of ophthalmic diseases, such as dry eye syndrome and neurotrophic keratopathy; and OKN-007 for the treatment of glioblastoma brain tumor. It is also involved in the wholesale of vaccines, as well as manufactures electrical and electronic components, such as motors, pumps, and transformers. The company was formerly known as G-treeBNT Co., Ltd. and changed its name to HLB Therapeutics Co.,Ltd. in December 2021. HLB Therapeutics Co.,Ltd. was founded in 2000 and is headquartered in Seongnam, South Korea.
Show more...
CEO
Mr. Doug Jang
Pekerja
98
Negara
KR
ISIN
KR7115450009